Position in RCEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$61,950
+$6,450 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 73 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $123,523,761 across 32 Medical Devices names. RCEL ranks #29 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
72,655 | $22,874,700 | |
| 2 | GMED |
Globus Medical Inc
|
211,000 | $16,671,110 | |
| 3 | PEN |
Penumbra Inc
|
52,423 | $16,552,562 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
144,850 | $12,470,136 | |
| 5 | BIO |
Bio-Rad Laboratories, Inc.
|
25,900 | $7,604,499 | |
| 6 | 251,000 | $6,244,880 | |||
| 7 | STE |
STERIS plc
|
22,700 | $4,779,939 | |
| 8 | DXCM |
Dexcom Inc
|
69,600 | $4,687,560 |
All Filings in RCEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,950 | 15,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $55,500 | 15,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $91,425 | 26,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $178,850 | 35,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $185,150 | 35,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||